https://openbell.ai/ 2026-10-24T17:43:06.943Z hourly 1.0 https://openbell.ai/support 2026-10-24T17:43:06.943Z monthly 0.7 https://openbell.ai/privacy 2026-10-24T17:43:06.943Z monthly 0.5 https://openbell.ai/terms 2026-10-24T17:43:06.943Z monthly 0.5 https://openbell.ai/feed.json 2026-10-24T17:43:06.943Z hourly 0.8 https://openbell.ai/news/KOTAKBANK:1792855928000 2026-10-24T15:32:08.000Z daily 0.9 https://cdn.brandfetch.io/KOTAKBANK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kotak Mahindra Bank Reports 26% Growth in Q2 Consolidated Profit Kotak Mahindra Bank Limited reported a consolidated profit after tax (PAT) of Rs 5,645 crore for Q2, representing a 26% increase year-over-year. Additionally, the bank achieved a 16% growth in net interest income (NII) for the quarter ending September 2026. https://openbell.ai/news/SBIN:1792855883000 2026-10-24T15:31:23.000Z daily 0.9 https://cdn.brandfetch.io/SBIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud State Bank of India Implements Policy Framework for New Trade Regulations State Bank of India has launched a policy framework to assist customers with new foreign exchange reporting regulations for exports and imports, effective October 1, 2026. The bank is one of only two institutions among 90 to offer such guidance, addressing challenges faced by service exporters and MSMEs who must complete a complex five-page Export Declaration Form to receive payments. This initiative aims to clarify compliance requirements amidst industry confusion. https://openbell.ai/news/CPAC:1792850506000 2026-10-24T14:01:46.000Z daily 0.9 https://cdn.brandfetch.io/CPAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Holcim Reports Q3 2026 Results Highlighting Cementos Pacasmayo Acquisition Impact Holcim's Q3 2026 earnings report emphasized the positive impact of its acquisition of Cementos Pacasmayo on its Latin American operations. The integration has led to significant growth in the region, showcasing the strategic success of the acquisition finalized earlier in the year. This development highlights Holcim's efforts to expand its market presence in Latin America. https://openbell.ai/news/PINE:1792847098000 2026-10-24T13:04:58.000Z daily 0.9 https://cdn.brandfetch.io/PINE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alpine Income Property Trust Outlines 2026 AFFO Guidance Alpine Income Property Trust has set its adjusted funds from operations (AFFO) guidance for 2026 at a range of $2.20 to $2.22 per share. This outlook is bolstered by an acceleration in the company's property acquisition strategy, providing investors with clear targets for its core operational performance in the upcoming fiscal year. https://openbell.ai/news/BOLT:1792847098000 2026-10-24T13:04:58.000Z daily 0.9 https://cdn.brandfetch.io/BOLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement Bolt Biotherapeutics, Inc. has announced the acquisition of Prana Therapies, Inc. through a stock-for-stock reverse merger, with Prana's equity exchanged for Bolt common and Series D non-voting convertible preferred stock. Concurrently, Bolt has secured a $120 million private placement to extend its cash runway into 2028, which includes warrants potentially worth an additional $60 million. Dr. Sheila Gujrathi, co-founder and former CEO of Prana, has been appointed as Bolt's Chief Strategy Officer and joined its board of directors. https://openbell.ai/news/ENCR:1792847098000 2026-10-24T13:04:58.000Z daily 0.9 https://cdn.brandfetch.io/ENCR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Encore Technologies Announces Portfolio Milestone and Board Reconstitution Encore Technologies Corp. announced a significant milestone for its portfolio company, Solstar Space Co., which successfully demonstrated space communications technology during a NASA mission. This achievement follows Encore's strategic investment of approximately US$1.16 million in Solstar, highlighting its commitment to the commercial space economy. Additionally, Encore reconstituted its board, appointing co-founder Matthew Sroka and accepting the resignation of founding shareholder James Reid. https://openbell.ai/news/FAT:1792847096000 2026-10-24T13:04:56.000Z daily 0.9 https://cdn.brandfetch.io/FAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Foremost Clean Energy Enters Joint Venture Agreement with Denison Mines Foremost Clean Energy Ltd. has entered into a joint venture agreement with Denison Mines Corp. to develop its GR and Blackwing uranium properties in the Athabasca Basin. Foremost will sell a 31% interest in these properties for a total consideration of $650,000 and will issue 1,031,191 share purchase warrants with a five-year term at an exercise price of $1.80 per share, which is over 175% above its closing share price on October 22, 2026. The warrants will have an ownership cap to limit Denison's stake in Foremost to 19.95%. https://openbell.ai/news/GOAT:1792847095000 2026-10-24T13:04:55.000Z daily 0.9 https://cdn.brandfetch.io/GOAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud GOAT Industries Ltd. Enters Definitive Agreement to Acquire Epoxy AI Customer Contract Revenues GOAT Industries Ltd. has entered into a definitive agreement to acquire customer contract revenues from Epoxy AI, LLC, dated October 20, 2026. GOAT will issue 11,377,600 common shares at a deemed price of C$0.25 per share in exchange for the rights to revenues from six customer contracts, including those with U.S. Tribal casinos. The transaction aims to enhance GOAT's BetSource technology platform in the U.S. gaming and sports betting markets, with the contract assignment expected to be completed within six months. https://openbell.ai/news/ASG:1792847093000 2026-10-24T13:04:53.000Z daily 0.9 https://cdn.brandfetch.io/ASG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aurora Spine Announces Publication of REFINE Study's 12-Month Results Aurora Spine Corporation announced the publication of the 12-month results from the REFINE study in the International Journal of Spine Surgery on October 9, 2026. The study evaluated the company's ZIP MIS Interlaminar Fusion System in patients with symptomatic neurogenic claudication due to lumbar spinal stenosis and degenerative disc disease. It was a multicenter trial involving spine surgeons and interventional pain specialists. https://openbell.ai/news/RAIN:1792847093000 2026-10-24T13:04:53.000Z daily 0.9 https://cdn.brandfetch.io/RAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rain Enhancement Technologies Reports Preliminary Warm-Season Precipitation Enhancement Results Rain Enhancement Technologies Holdco, Inc. reported preliminary results indicating over 20% precipitation enhancement from its Weather Enhancement Technology Array (WETA) in Utah's La Sal Mountains between April and July 2026. The findings were based on two statistical models, both showing a positive effect with over 80% probability. The company previously reported similar results for winter 2025-26, and operations were suspended during National Weather Service flood warnings in August and September 2026. https://openbell.ai/news/HODO:1792847088000 2026-10-24T13:04:48.000Z daily 0.9 https://cdn.brandfetch.io/HODO/w/400/h/400?c=1idopYfmtR7ZKg8QMud House of Doge Inc. Announces Acquisition of McQueen Labs Tokenization Platform and Assets House of Doge Inc. (NASDAQ: HODO) has announced its acquisition of the tokenization platform and credit assets of McQueen Labs Inc., aiming to enhance its presence in the $51 billion tokenized real-world asset market. The company plans to introduce tokenized yield vaults and is exploring financing alternatives, including a reverse stock split pending stockholder approval. Curt Hopkins, the former CEO of McQueen Labs, has been appointed as the interim CEO and CFO of House of Doge Inc. https://openbell.ai/news/KTTA:1792847087000 2026-10-24T13:04:47.000Z daily 0.9 https://cdn.brandfetch.io/KTTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Pasithea Therapeutics reported positive clinical results for its lead drug candidate, PAS-004, from a Phase 1 trial in advanced cancer patients, presented at the 2026 ESMO Congress. The trial showed prolonged stable disease in heavily pre-treated patients, with some remaining on treatment for over 300 days, and two patients for more than 500 days. The drug demonstrated a favorable safety profile, with no Grade 3 treatment-related adverse events or discontinuations. PAS-004 is also being evaluated for RASopathies and MAPK pathway-driven tumors. https://openbell.ai/news/CEXY:1792847085000 2026-10-24T13:04:45.000Z daily 0.9 https://cdn.brandfetch.io/CEXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Copper One Resources Corp. Commences Phase 2 Drill Program at Majuba Hill Copper One Resources Corp. has initiated a Phase 2 diamond core drilling program at its Majuba Hill project in Nevada, which will involve up to 10,000 feet of drilling. This program aims to systematically test priority targets and support the establishment of a maiden mineral resource estimate under NI 43-101 standards. Evolve Exploration Nevada, LLC has been engaged to conduct the drilling, and real-time operational data will be provided through the EVX Connect platform. Assay results from the earlier Phase 1 program are pending validation. https://openbell.ai/news/ECM.H:1792847081000 2026-10-24T13:04:41.000Z daily 0.9 https://cdn.brandfetch.io/ECM.H/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ecolomondo Corporation Receives Court Approval for Asset Sale Ecolomondo Corporation has received court approval from the Superior Court of Québec for an Asset Purchase Agreement with Tire Reviver Inc., involving the sale of nearly all its assets as part of its restructuring under the Companies’ Creditors Arrangement Act (CCAA). The transaction includes assets from several subsidiaries, including Ecolomondo Environmental (Hawkesbury) Inc. and Ecolomondo Advanced Carbon Technologies Inc. Net proceeds from the sale will be allocated according to applicable legislation, with further updates on the CCAA proceedings to follow. https://openbell.ai/news/CGD:1792847080000 2026-10-24T13:04:40.000Z daily 0.9 https://cdn.brandfetch.io/CGD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Carlin Gold Corporation Proposes Royalty-Focused Spinout Carlin Gold Corporation has announced a plan to create a spinoff entity, Carlin Gold Royalty Corporation, which will hold the company's royalty interests in Nevada and Yukon. Shareholders will receive one-half of a share in the new company for each share they own in Carlin Gold. This strategic move aims to allow Carlin Gold to concentrate on advancing the Cortez Summit gold project, with the arrangement expected to take effect in January 2027. https://openbell.ai/news/CWL:1792847080000 2026-10-24T13:04:40.000Z daily 0.9 https://cdn.brandfetch.io/CWL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Caldwell Announces Sale of IQTalent Caldwell has sold its subsidiary, IQTalent Partners, Inc., to WinMil, Inc. for approximately $4.7 million, which includes $3.2 million in cash and 1.45 million Caldwell common shares. The divestiture aligns with Caldwell's strategic focus on executive search and advisory services, as the company acquired IQTalent in 2020 but found it no longer aligned with its long-term goals. A two-year referral agreement has been established between the companies to ensure continued collaboration. Caldwell's board will assess the cash proceeds for future capital allocation. https://openbell.ai/news/AEP:1792847075000 2026-10-24T13:04:35.000Z daily 0.9 https://cdn.brandfetch.io/AEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beacon Securities Reiterates Buy Rating on Atlas Engineered Products Following Clinton Facility Visit Beacon Securities analyst Russell Stanley has reiterated a 'Buy' rating on Atlas Engineered Products (AEP) with a price target of $1.00 following a visit to their new $20-million robotic roof truss manufacturing facility in Clinton, Ontario. The facility, funded by equity financing and federal government support, has commenced production and is expected to enhance productivity due to its high level of automation. Currently operating one production line, the facility is anticipated to contribute to market share growth, with the company set to report its third-quarter results in late November. https://openbell.ai/news/QNC:1792847074000 2026-10-24T13:04:34.000Z daily 0.9 https://cdn.brandfetch.io/QNC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Quantum eMotion Corp. Trading Halt On October 23, 2026, the Canadian Investment Regulatory Organization (CIRO) halted trading for Quantum eMotion Corp. (TSXV: QNC) at 09:26 AM ET due to 'Pending News.' This trading halt is a standard regulatory measure to maintain fair and orderly markets while awaiting material information from the company. https://openbell.ai/news/ATNM:1792847071000 2026-10-24T13:04:31.000Z daily 0.9 https://cdn.brandfetch.io/ATNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Actinium Pharmaceuticals to Present Phase 1 Study of ATNM-400 at ESMO 2026 Actinium Pharmaceuticals will present its Phase 1 study of ATNM-400, a HER3-targeted radiotherapy for metastatic castration-resistant prostate cancer, at the ESMO Congress 2026 in Madrid. This multicenter, open-label trial aims to evaluate the safety, tolerability, and antitumor activity of ATNM-400, which combines a HER3-targeting antibody with Actinium-225. The presentation is expected to enhance visibility into the clinical progress of this investigational therapy. https://openbell.ai/news/AVN:1792847070000 2026-10-24T13:04:30.000Z daily 0.9 https://cdn.brandfetch.io/AVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.S. Department of Energy Designates Helium as a Critical Material On October 23, 2026, the U.S. Department of Energy designated helium as a critical material, highlighting its importance in semiconductor manufacturing and the potential for global supply disruptions. This designation is expected to lead to increased federal financing for helium producers and improved government oversight of the resource. Avanti Helium Corp. CEO Chris Bakker supported the decision, stating it is crucial for U.S. self-sufficiency in helium and will aid in the exploration of new reserves to boost North American supply. https://openbell.ai/news/ELTX:1792847064000 2026-10-24T13:04:24.000Z daily 0.9 https://cdn.brandfetch.io/ELTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Elicio Therapeutics Announces Positive Phase 2 AMPLIFY-7P Results for Camupepimut Elicio Therapeutics, Inc. reported positive results from its Phase 2 AMPLIFY-7P study of camupepimut (ELI-002 7P) for treating mutant KRAS-driven pancreatic ductal adenocarcinoma. The study showed a 53% reduction in the risk of recurrence or death compared to observation, with a multivariable adjusted hazard ratio of 0.47 (p=0.0086). Furthermore, 99% of evaluable patients exhibited mutant KRAS-specific T-cell responses, which will inform future patient stratification and dosing in Phase 3 development. https://openbell.ai/news/ZEFI:1792847064000 2026-10-24T13:04:24.000Z daily 0.9 https://cdn.brandfetch.io/ZEFI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zefiro Methane Corp. Announces Closing of C$5.0 Million Non-Brokered Private Placement Zefiro Methane Corp. has successfully completed a non-brokered private placement, raising approximately C$5.0 million. The company issued 7,575,758 units at a price of C$0.66 per unit. This financing was officially announced on October 23, 2026. https://openbell.ai/news/MBOT:1792847057000 2026-10-24T13:04:17.000Z daily 0.9 https://cdn.brandfetch.io/MBOT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citizens JMP Initiates Coverage of Microbot Medical with Buy Rating Citizens JMP has begun coverage of Microbot Medical Inc. (MBOT) with a Buy rating and established a price target of $2.50 per share. This marks the initiation of new market coverage for the medical device company. https://openbell.ai/news/SUNS:1792847050000 2026-10-24T13:04:10.000Z daily 0.9 https://cdn.brandfetch.io/SUNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sunrise Realty Trust Stockholders Approve Merger with Southern Realty Trust On October 23, 2026, stockholders of Sunrise Realty Trust, Inc. (Nasdaq: SUNS) approved the issuance of approximately 8,464,955 shares to facilitate its merger with Southern Realty Trust Inc. (SRT), with 91.6% of the votes in favor from 59.5% of outstanding shares. The merger is set to close on November 5, 2026, pending customary conditions, and will result in SRT merging into a wholly owned subsidiary of SUNS, enhancing their commercial real estate lending platform under Tannenbaum Capital Group. https://openbell.ai/news/APXC:1792847049000 2026-10-24T13:04:09.000Z daily 0.9 https://cdn.brandfetch.io/APXC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apex Critical Metals Corp. Completes Nasdaq Listing and US$1.86 Million Offering Apex Critical Metals Corp. has completed a public offering in the U.S., raising gross proceeds of US$1.86 million by selling 400,000 American Depositary Shares (ADSs) at US$4.65 each. The company has also begun trading on the Nasdaq Capital Market under the ticker 'APXC' as of October 23, 2026. The net proceeds will be utilized for working capital and to advance its drill program at the Rift Rare Earth Project in Nebraska. https://openbell.ai/news/CPIX:1792847048000 2026-10-24T13:04:08.000Z daily 0.9 https://cdn.brandfetch.io/CPIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cumberland Pharmaceuticals Announces Top-Line Results from Phase 2a ASSIST-SSc Trial Cumberland Pharmaceuticals Inc. announced top-line results from its Phase 2a ASSIST-SSc trial for its oral ifetroban product candidate, which was found to be generally well-tolerated with a safety profile consistent with previous studies. The trial focused on safety and tolerability in patients with systemic sclerosis but was not designed to evaluate efficacy, limiting definitive conclusions. The company has consulted with clinical experts regarding the results from both the dcSSc and SSc-PAH cohorts. https://openbell.ai/news/S:1792847047000 2026-10-24T13:04:07.000Z daily 0.9 https://cdn.brandfetch.io/S/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sherritt Announces Operational Reduction at Moa Joint Venture Due to Fuel Constraints Sherritt International Corporation is reducing operations at its Moa joint venture in Cuba due to fuel supply constraints, pausing mining operations and placing the processing plant on standby for maintenance. The timeline for resuming fuel deliveries is uncertain, but the Fort Saskatchewan refinery in Alberta has enough feed inventory to operate until mid-April. The company is exploring options to maintain production and liquidity, and plans to provide updated guidance for 2026 once supply chain conditions improve. https://openbell.ai/news/TCGX:1792847040000 2026-10-24T13:04:00.000Z daily 0.9 https://cdn.brandfetch.io/TCGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud TCGX Leads $250 Million PIPE Financing for Zai Lab TCGX led a $250 million PIPE financing for Zai Lab Limited, involving the sale of 11,340,000 American Depositary Shares at $22.04 each. The net proceeds will primarily support the global development of Zai Lab's DLL3-targeting antibody-drug conjugate, zocilurtatug pelitecan. The transaction is expected to close on or about October 27, 2026, pending customary closing conditions. https://openbell.ai/news/OAK.PRB:1792847035000 2026-10-24T13:03:55.000Z daily 0.9 https://cdn.brandfetch.io/OAK.PRB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oaktree Capital Management Commits $1 Billion to New Investment Firm Cobblers Cove Capital Oaktree Capital Management, a subsidiary of Brookfield Asset Management, has committed $1 billion to the establishment of Cobblers Cove Capital, a new investment firm in Charleston, S.C. Led by Matt Perkal and Ben Fader-Rattner, Cobblers Cove will focus on North American public and private markets, including control acquisitions and corporate carve-outs. Oaktree plans to co-invest with Cobblers Cove in future deals, building on their previous partnership in the acquisition of Family Dollar. https://openbell.ai/news/ESOA:1792847035000 2026-10-24T13:03:55.000Z daily 0.9 https://cdn.brandfetch.io/ESOA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Energy Services of America Completes Acquisition of FAMCO, Inc. Assets Energy Services of America Corporation, through its subsidiary FAMCO Acquisition, Inc., has completed the acquisition of substantially all operating assets of FAMCO, Inc. for a base purchase price of $6.95 million, paid in cash and common stock. This acquisition aims to enhance Energy Services' utility construction operations by integrating FAMCO's expertise in water and sewer infrastructure, experienced workforce, and established customer relationships. https://openbell.ai/news/MGNX:1792847034000 2026-10-24T13:03:54.000Z daily 0.9 https://cdn.brandfetch.io/MGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud MacroGenics Announces Positive Interim Phase 1 Results for MGC026 MacroGenics, Inc. announced positive interim results from its Phase 1 clinical study of MGC026, a B7-H3-directed antibody-drug conjugate, presented at the ESMO 2026 Congress. The study showed a 27% best overall response rate in heavily pretreated patients with squamous cell carcinoma of the head and neck. The drug demonstrated a manageable safety profile with no treatment-related discontinuations. Following these results, MacroGenics plans to begin a front-line SCCHN cohort to evaluate MGC026 in combination with pembrolizumab. https://openbell.ai/news/SVI:1792847025000 2026-10-24T13:03:45.000Z daily 0.9 https://cdn.brandfetch.io/SVI/w/400/h/400?c=1idopYfmtR7ZKg8QMud StorageVault Canada Inc. Price Target Cut by Analysts On October 23, 2026, analysts lowered the price target for StorageVault Canada Inc. (SVI) to C$5.15 per share. This adjustment indicates a change in the analysts' outlook for the company, although no specific reasons or previous price targets were disclosed. https://openbell.ai/news/MRAM:1792847014000 2026-10-24T13:03:34.000Z daily 0.9 https://cdn.brandfetch.io/MRAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Everspin Technologies Expands MRAM Focus to AI and Satellite Markets Everspin Technologies is expanding its focus on magnetoresistive random-access memory (MRAM) to include high-growth sectors such as AI servers, data centers, and satellite systems. This strategic shift marks a departure from its traditional industrial applications, aiming to capitalize on opportunities in high-performance computing and aerospace markets. https://openbell.ai/news/AMTB:1792847007000 2026-10-24T13:03:27.000Z daily 0.9 https://cdn.brandfetch.io/AMTB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amerant Bancorp Inc. Provides Q4 2026 Financial Guidance Amerant Bancorp Inc. provided its financial guidance for Q4 2026 during its third-quarter earnings call, forecasting total loans to reach $7.3 billion and total deposits to hit $8.5 billion by the end of the quarter. The company also set a target for its net interest margin (NIM) between 3.65% and 3.70%, indicating its expectations for growth and profitability. https://openbell.ai/news/TCBX:1792847004000 2026-10-24T13:03:24.000Z daily 0.9 https://cdn.brandfetch.io/TCBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud StoneX Maintains Buy Rating for Third Coast Bancshares StoneX has reaffirmed its 'Buy' rating for Third Coast Bancshares, Inc. (NYSE: TCBX), indicating a continued positive outlook on the company's performance. This rating was reported on October 23, 2026. https://openbell.ai/news/TMP:1792847004000 2026-10-24T13:03:24.000Z daily 0.9 https://cdn.brandfetch.io/TMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tompkins Financial Corporation Increases Quarterly Cash Dividend Tompkins Financial Corporation has raised its quarterly cash dividend to $0.74 per share, an increase from the previous $0.70 per share. The new dividend will be payable on November 13, 2026, to shareholders on record as of November 6, 2026. This adjustment reflects a strategic change in the company's capital allocation. https://openbell.ai/news/SGR.UN:1792846999000 2026-10-24T13:03:19.000Z daily 0.9 https://cdn.brandfetch.io/SGR.UN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Slate Grocery REIT Announces Receipt of Interim Order for Proposed Acquisition Slate Grocery REIT has received an interim order from the Ontario Superior Court of Justice related to its proposed acquisition by EP/BRX Holdings LLC, a joint venture involving Brixmor Property Group Inc. and Everview Partners, L.P. This order is a procedural step in the acquisition process, and the company has also shared details regarding the upcoming meeting and circular associated with the transaction. https://openbell.ai/news/PACB:1792846999000 2026-10-24T13:03:19.000Z daily 0.9 https://cdn.brandfetch.io/PACB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stephens Maintains Buy Rating and Raises Price Target for PacBio Stephens analyst Mason Carrico has maintained a 'Buy' rating for Pacific Biosciences of California, Inc. (PacBio) and raised the price target from $2.00 to $2.50. This adjustment is based on the analyst's assessment of the company's stock performance and market position, as reported by the independent financial analysis platform TipRanks. https://openbell.ai/news/LPTH:1792846999000 2026-10-24T13:03:19.000Z daily 0.9 https://cdn.brandfetch.io/LPTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Adjusts LightPath Technologies Price Target Piper Sandler has lowered its price target for LightPath Technologies, Inc. (LPTH) from $15.00 to $13.00 while maintaining its investment rating on the company. This adjustment is part of the latest analyst actions concerning the optical components manufacturer. https://openbell.ai/news/SG:1792846995000 2026-10-24T13:03:15.000Z daily 0.9 https://cdn.brandfetch.io/SG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Raises Sweetgreen Price Target to $13.00 Citigroup has raised its price target for Sweetgreen, Inc. (SG) from $8.00 to $13.00 per share. This increase is based on a revised valuation assessment of the fast-casual restaurant chain. https://openbell.ai/news/QMCO:1792846994000 2026-10-24T13:03:14.000Z daily 0.9 https://cdn.brandfetch.io/QMCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Initiates Coverage of Quantum Corporation with Overweight Rating Cantor Fitzgerald has initiated coverage of Quantum Corporation (QMCO) with an Overweight rating and established a price target of $29 for the company's stock. This move offers a fresh market perspective on Quantum's valuation and growth potential in the data storage and management sector. https://openbell.ai/news/RCAT:1792846994000 2026-10-24T13:03:14.000Z daily 0.9 https://cdn.brandfetch.io/RCAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Hold Rating on Red Cat Holdings, Lowers Price Target Piper Sandler analyst Clarke Jeffries has maintained a 'Hold' rating on Red Cat Holdings, Inc. (RCAT) while lowering the price target from $9 to $6. This adjustment reflects the analyst's assessment of the company's valuation and market position. https://openbell.ai/news/ZYME:1792846990000 2026-10-24T13:03:10.000Z daily 0.9 https://cdn.brandfetch.io/ZYME/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zymeworks Presents Phase 1 Clinical Data for ZW191 at ESMO Congress 2026 Zymeworks presented Phase 1 clinical data for ZW191 at the ESMO Congress 2026, showing a confirmed objective response rate of 64.5% at a 6.4 mg/kg dose in patients with high-grade serous platinum-resistant ovarian cancer. The median duration of response is not yet reached, with a six-month progression-free survival rate of 61% based on a median follow-up of seven months. The company is also exploring strategic partnering opportunities with MTS Healthcare to fund further development of ZW191. https://openbell.ai/news/AVBP:1792846989000 2026-10-24T13:03:09.000Z daily 0.9 https://cdn.brandfetch.io/AVBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud ArriVent BioPharma to Present Phase 1 Data for ARR-217 at ESMO Congress 2026 ArriVent BioPharma, Inc. will present Phase 1 clinical trial data for its lead antibody-drug conjugate candidate, ARR-217, at the ESMO Congress 2026 in Madrid from October 23 to October 27, 2026. The results will be shared in a rapid oral presentation, and a virtual webinar is scheduled for October 26, 2026, to discuss the clinical data further. ARR-217 is being developed for gastrointestinal cancers, with exclusive rights held by ArriVent outside of Greater China through a collaboration with Lepu Biopharma Co., Ltd. https://openbell.ai/news/MTL:1792846988000 2026-10-24T13:03:08.000Z daily 0.9 https://cdn.brandfetch.io/MTL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Desjardins Analyst Raises Mullen Group Price Target Following Operational Performance Desjardins analyst Benoit Poirier has increased the price target for Mullen Group Ltd. to C$34 from C$31, citing strong operational performance. The Specialized & Industrial division reported operating margins of 24.7%, exceeding the forecast of 22.4%, and generated free cash flow of C$62 million, enhancing the company's net leverage. This financial strength positions Mullen Group to pursue acquisitions and benefit from anticipated growth in freight activity and energy investments. https://openbell.ai/news/WU:1792846984000 2026-10-24T13:03:04.000Z daily 0.9 https://cdn.brandfetch.io/WU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Western Union Launches Stablecoin Payments Service Western Union has launched a new payments service that allows customers to send funds using USDPT™ stablecoins, issued by Anchorage Digital Bank on the Solana blockchain. This initiative is designed to reduce the time and cost of international remittances, enabling recipients to collect stablecoins through a Western Union wallet or at agent locations globally. The service is part of Western Union's strategy to modernize cross-border money movement and complements its existing digital offerings. https://openbell.ai/news/CELC:1792846967000 2026-10-24T13:02:47.000Z daily 0.9 https://cdn.brandfetch.io/CELC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study Celcuity Inc. presented updated results from the PIK3CA mutation cohort of its Phase 3 VIKTORIA-1 clinical trial at the ESMO Congress 2026. The trial evaluates gedatolisib, the company's lead therapeutic candidate, in patients with HR+/HER2- advanced breast cancer, showcasing new clinical data on its efficacy. This presentation underscores Celcuity's ongoing progress in its late-stage clinical development for targeted oncology therapies. https://openbell.ai/news/CALM:1792846943000 2026-10-24T13:02:23.000Z daily 0.9 https://cdn.brandfetch.io/CALM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Antitrust Allegations Against Cal-Maine Foods and Egg Industry The Department of Justice has filed an antitrust lawsuit against Cal-Maine Foods, Hickman's Egg Ranch, and Versova, alleging that they coordinated for nearly three years to manipulate egg price benchmarks. The companies have denied wrongdoing and no trial is anticipated. Farm Action estimates that Cal-Maine could face a financial obligation of around $2.8 million, which is considered a small fraction of the company's profits for fiscal year 2025. https://openbell.ai/news/PBLS:1792846941000 2026-10-24T13:02:21.000Z daily 0.9 https://cdn.brandfetch.io/PBLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Parabilis Medicines Announces Updated Phase 1/2 Data for Zolucatetide in Desmoid Tumors Parabilis Medicines presented updated Phase 1/2 trial results for zolucatetide at the ESMO Congress 2026, showing a 72.2% objective response rate and a 100% disease control rate among patients treated with a starting dose of ≥450 mg. These results, based on data as of June 22, 2026, will guide the FDA-aligned dose selection for the upcoming PEDESTAL Phase 3 trial, set to begin in the first half of 2027, with topline results expected in 2029. https://openbell.ai/news/TVTX:1792846936000 2026-10-24T13:02:16.000Z daily 0.9 https://cdn.brandfetch.io/TVTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Travere Therapeutics Presents New Biomarker Data for FILSPARI at ASN Kidney Week 2026 At the ASN Kidney Week 2026, Travere Therapeutics presented new biomarker data from its Phase 3 PROTECT study, indicating that FILSPARI (sparsentan) may alter the disease pathophysiology in patients with IgA nephropathy. The findings provide additional insights into the medication's dual mechanism of action, underscoring the company's commitment to showcasing the clinical benefits of its lead product for rare kidney diseases.